Inflammation and thrombosis: the clot thickens.

By Peter Libby, D. Simon. Circulation, 2001

632 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, background): “IL-6 levels may correlate with disease severity, and a procoagulant profile (21).”
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003, neutral): “Inflammation promotes thrombosis and vice versa [108].”
Cardiovascular complications in COVID-19 (2020, neutral): “Disruption in immune system regulation, increased metabolic demand, and procoagulant activity likely account for some of the increased risk of adverse outcomes in those with COVID-19-related cardiovascular disease (CVD) [8, 9, 14] .”